Sprinkles, Jessica K.; Qin, Qiyao; Steward, Charles; Howard, Annie Green; Lulla, Anju; Hullings, Autumn G.; Carr, J. Jeffrey; Shaikh, Saame Raza; Avery, Christy L.; North, Kari E.; Gordon-Larsen, Penny; Meyer, Katie A. (2026)..PLOS ONE, 21(3), e0341462.
This study examines how different types of fats and related molecules in the blood are linked to metabolic-associated steatotic liver disease (MASLD), a condition where excess fat builds up in the liver. While this buildup mainly involves triacylglycerols (TAGs) (a common form of fat), other lipids (fat-like molecules) and nutrients—especially those involved in choline metabolism—may also play important roles. Choline is a nutrient that helps the liver package and export fats using particles called very low-density lipoproteins (VLDL), which carry fat through the bloodstream. However, large population studies that look at these factors together have been limited.
Using data from over 1,000 middle-aged adults in the CARDIA study, the researchers analyzed blood samples to measure a wide range of lipids (lipidomics, the large-scale study of fats in the body) and choline-related compounds. They also assessed liver fat using CT scans. They found that higher levels of certain lipids—such as TAGs, diacylglycerols (DAGs), and dihydroceramides (DCERs)—were linked to a greater likelihood of MASLD, while higher levels of lactosylceramides (LCERs) were linked to a lower likelihood. When looking more closely at phosphatidylcholines (PCs)—a class of lipids important for fat transport—their relationship with MASLD depended on the types of fatty acids (FA composition) they contained, suggesting that not all PCs behave the same way in the disease process.
The study also found that betaine, a molecule derived from choline, was associated with a lower risk of MASLD. In contrast, a combined “lipid risk score” based on multiple lipid types was positively associated with choline levels but negatively associated with betaine. Overall, these findings highlight complex interactions between different fats and choline-related molecules in the development of MASLD. They suggest that both the types of fats and how the body processes choline may influence liver health, offering potential clues for identifying biomarkers (measurable indicators of disease) and better understanding the underlying biology of the condition.

Fig 1.Multivariable-adjusted associations between lipid classes and metabolic associated steatotic liver disease.
Multivariable-adjusted risk ratios (95% CI) from a Poisson regression model adjusted for race (Black/White), examination center (Birmingham, AL; Chicago, IL; Minneapolis, MN; Oakland, CA), age (continuous), attained education (continuous), sex (male/female), smoking (current/not current), physical activity score (continuous), dietary intake as food groups (continuous), caloric intake (continuous), a priori diet quality score (continuous), eGFR (continuous), BMI (continuous), hypertension (yes/no), and lipid-lowering cholesterol medication use (yes/no). MASLD cases/non-cases = 219/764; Observations removed due to missing covariate data = 133.CE cholesteryl ester, CER,DAG徱⳦DZ,DCER徱dz,HCERDz,LCERٴDz,LPEDZDzپDZԱ,MAGDzԴDz⳦DZ,PCDzپDZԱ,PEDzپٳԴDZԱ,PIDzپԴDzٴDZ,SMԲdz,TAGٰ⳦DZ.